Will the metaverse be part of the future of healthcare

In recent times, we’ve all witnessed the transformative potential of emerging technology.

It has facilitated the continuance of our way of life. But as we begin to explore immersive experiences like AR, VR, and the Metaverse, it is clear we’ve barely scratched the surface. One of the most remarkable characteristics of this technology is its inclusivity. Whether it’s because of geographic, demographic, or physical limitations, many people have struggled to engage with traditional healthcare. That is about to change.

At Capgemini, we strive to keep our partners ahead of the curve. For our healthcare partners, this means highlighting the many benefits of emerging Web3, blockchain, and Metaverse tech. With €4.23bln invested in HealthTech start-ups in only 2021, a three-fold increase from 2020, the future of healthcare is starting to take shape.

From remote therapy and surgical training to digital-twin diagnostics, the Metaverse can achieve so much more than social networking and entertainment. It can be part of the future of healthcare.

Download the report

Our Experts

I started my career as a consultant in 2000 and gained experience in major transformation projects in Manufacturing, Quality, Supply Chain, and clinical operations, with a strong focus on Industry 4.0 since 2015. I supported General Management in the Life Sciences sector (Pharmaceutical companies, Medical Device companies, and Chemical companies) as well as other large industrial and services companies. I now manage the Life Sciences department at Capgemini Invent in France and co-develop the Life Sciences in Switzerland.

With +10-year experience in pharmaceutical industry, I bring an international experience in Life Science strategy and management consulting, digital transformation projects, product management, business development, team management, digital health, and agile principles

Rayane has contributed to the definition of global strategies for several Pharma companies. Her professional thesis at ESCP Europe was dedicated to the study of “Growth opportunities and portfolio expansion strategies for the pharmaceutical industry”. Within Capgemini Invent, she helps in the deployment of transformation strategies and the design of innovative solutions, such as Digital Therapeutics. Convinced that virtual and immersive technologies can enhance and accelerate access to care for patients, she is actively invested in structuring their potential use cases.

Neïla Zehani is a Biomedical & e-Health Engineer and completed her studies with an MSc in Pharmaceutical and Biotechnology Management at Grenoble Ecole de Management. She dedicated her professional thesis to the digitalization of clinical trials. Within the Life Sciences team of Capgemini Invent, she supports Pharma in their digital transformation strategies, particularly in patient-centric clinical trials. Passionate about the potential of virtual and augmented reality technologies, she is actively involved in the design of care in a virtual world.